• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

US - An American nurse with exposure to Ebola in Sierra Leone admitted at NIH Clinical Center - Discharged

Pathfinder

Editor, Senior Moderator
For Immediate Release: Thursday, December 11, 2014

Patient with exposure to Ebola to be admitted at NIH Clinical Center

Later today, the National Institutes of Health expects to admit a patient with exposure to the Ebola virus to the NIH Clinical Center?s special clinical studies unit for observation and to enroll in a clinical protocol. The patient is an American nurse who was volunteering services in an Ebola treatment unit in Sierra Leone.

The special clinical studies unit is specifically designed to provide high-level isolation capabilities and is staffed by infectious diseases and critical care specialists. The unit staff is trained in strict infection control practices optimized to prevent spread of potentially transmissible agents such as Ebola. In addition, access to the unit will be strictly controlled.

No additional details about the patient are being shared at this time.

NIH is taking every precaution to ensure the safety of our patients, NIH staff, and the public. This situation presents minimal risk to any of them.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH...Turning Discovery Into Health?

http://www.nih.gov/news/health/dec2014/od-11.htm

-------------------------------------------------------------------------------------------------------------------------
For Immediate Release: Thursday, December 11, 2014

UPDATE: Patient with exposure to Ebola arrives safely at NIH Clinical Center


A patient with exposure to the Ebola virus while in Sierra Leone has arrived safely at the NIH Clinical Center for observation and to enroll in a clinical protocol. The patient was transferred from an overseas location via private charter medevac in isolation and admitted to the NIH Clinical Center at approximately 12:42 p.m. EST.

The patient is an American nurse who was volunteering services in an Ebola treatment unit in Sierra Leone. Out of an abundance of caution, the patient has been admitted to the NIH Clinical Center?s special clinical studies unit that is specifically designed to provide high-level isolation capabilities and is staffed by infectious diseases and critical care specialists. The unit staff is trained in strict infection control practices optimized to prevent spread of potentially transmissible agents such as Ebola.

No additional details about the patient are being shared at this time.

NIH is taking every precaution to ensure the safety of our patients, NIH staff, and the public. This situation presents minimal risk to any of them.

For more information about clinical protocols, visit: http://www.nih.gov/health/clinicaltrials/basics.htm

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH...Turning Discovery Into Health?
NOTE

Please note correction on time of admittance: On December 11, 2014 the time the patient arrived at NIH was updated to 12:42 p.m. EST.

http://www.nih.gov/news/health/dec2014/od-11a.htm
 
For Immediate Release: Friday, December 19, 2014

Patient exposed to Ebola Discharged from NIH Clinical Center Today

Earlier today, the NIH Clinical Center discharged the patient who was admitted to the hospital on December 11 following a high-risk exposure to Ebola virus while providing bedside nursing care in Sierra Leone. We are happy to report that the patient has shown no clinical or laboratory evidence of Ebola infection and will complete 21 days of monitoring at a private residence in Virginia under the direction of the Virginia Department of Health. The patient feels well and has no fever. CDC guidelines pertaining to monitoring and isolation will be followed until the completion of the 21-day observation period from the time of reported exposure.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.


http://www.nih.gov/news/health/dec2014/od-19.htm
 
Back
Top